Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance

Polycystic ovary syndrome (PCOS) is a set of endocrine disorder syndrome characterized by ovulation disorder. Increased insulin resistance (IR) and compensatory hyperinsulinemia play a vital role in the pathogenesis of PCOS. Therefore, insulin sensitizing agents have been studied in the treatment of...

Full description

Bibliographic Details
Main Authors: Li Li, Yao Xiao, Jiahe Zhou, Hui Mo, Xiaofang Li, Yuancheng Li, Youfeng Wang, Minglin Zhong
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024003694
_version_ 1797328685551845376
author Li Li
Yao Xiao
Jiahe Zhou
Hui Mo
Xiaofang Li
Yuancheng Li
Youfeng Wang
Minglin Zhong
author_facet Li Li
Yao Xiao
Jiahe Zhou
Hui Mo
Xiaofang Li
Yuancheng Li
Youfeng Wang
Minglin Zhong
author_sort Li Li
collection DOAJ
description Polycystic ovary syndrome (PCOS) is a set of endocrine disorder syndrome characterized by ovulation disorder. Increased insulin resistance (IR) and compensatory hyperinsulinemia play a vital role in the pathogenesis of PCOS. Therefore, insulin sensitizing agents have been studied in the treatment of PCOS. Berberine (BBR) has been proved to alleviate IR in patients with PCOS, but the mechanism remained unclear. This study was aimed to verify the regulatory mechanism of BBR on PCOS-IR rats. Firstly, we established a female rat PCOS-IR model induced by dehydroepiandrosterone (DHEA) and found that estrus cycle was disrupted in the PCOS-IR group, serum fasting insulin (FINS) level and the homeostasis model assessment of insulin resistance (HOMA-IR) index were significantly higher than normal control group. BBR treatment could recover estrous cycle, reduce abnormal serum hormone levels like luteotropic hormone (LH) and testosterone (T). Most importantly, BBR could concentration-dependently reduce serum FINS level in PCOS-IR rat model. Meanwhile, BBR may improve the abnormal lipid metabolism levels in PCOS-IR group by decreasing low density lipoprotein (LDL), total cholesterol (TC) and triglyceride (TG). Histological results showed that BBR can also protect normal histological structures of ovaries in PCOS-IR rats. Our results indicated that BBR plays a protective role in PCOS-IR, increasing insulin sensitivity, improving hyperandrogens and recovering abnormal blood lipids. Therefore, Our research provides novel insights for therapeutic treatment of BBR in patients with glucolipid metabolic disturbances.
first_indexed 2024-03-08T06:55:16Z
format Article
id doaj.art-b52ce95e8c3b4790aa131ecff8bc4ec6
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-08T06:55:16Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-b52ce95e8c3b4790aa131ecff8bc4ec62024-02-03T06:37:00ZengElsevierHeliyon2405-84402024-01-01102e24338Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistanceLi Li0Yao Xiao1Jiahe Zhou2Hui Mo3Xiaofang Li4Yuancheng Li5Youfeng Wang6Minglin Zhong7Department of Obstetrics and Gynecology, Guangdong Women and Children Hospital, Guangzhou, Guangdong, 510010, China; Guangzhou Medical University, Guangzhou, Guangdong, 510000, China; Corresponding author. Department of Obstetrics and Gynecology, Guangdong Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 510010, China.State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, ChinaNaval Special Medical Center, Naval Medical University, Shanghai, 200082, ChinaFaculty of Chinese Medicine, Macau University of Science and Technology, Macao, 000853, ChinaDepartment of Obstetrics and Gynecology, Guangdong Women and Children Hospital, Guangzhou, Guangdong, 510010, ChinaDepartment of Obstetrics and Gynecology, Guangdong Women and Children Hospital, Guangzhou, Guangdong, 510010, China; Guangzhou Medical University, Guangzhou, Guangdong, 510000, ChinaFaculty of Chinese Medicine, Macau University of Science and Technology, Macao, 000853, ChinaDepartment of Obstetrics and Gynecology, Guangdong Women and Children Hospital, Guangzhou, Guangdong, 510010, ChinaPolycystic ovary syndrome (PCOS) is a set of endocrine disorder syndrome characterized by ovulation disorder. Increased insulin resistance (IR) and compensatory hyperinsulinemia play a vital role in the pathogenesis of PCOS. Therefore, insulin sensitizing agents have been studied in the treatment of PCOS. Berberine (BBR) has been proved to alleviate IR in patients with PCOS, but the mechanism remained unclear. This study was aimed to verify the regulatory mechanism of BBR on PCOS-IR rats. Firstly, we established a female rat PCOS-IR model induced by dehydroepiandrosterone (DHEA) and found that estrus cycle was disrupted in the PCOS-IR group, serum fasting insulin (FINS) level and the homeostasis model assessment of insulin resistance (HOMA-IR) index were significantly higher than normal control group. BBR treatment could recover estrous cycle, reduce abnormal serum hormone levels like luteotropic hormone (LH) and testosterone (T). Most importantly, BBR could concentration-dependently reduce serum FINS level in PCOS-IR rat model. Meanwhile, BBR may improve the abnormal lipid metabolism levels in PCOS-IR group by decreasing low density lipoprotein (LDL), total cholesterol (TC) and triglyceride (TG). Histological results showed that BBR can also protect normal histological structures of ovaries in PCOS-IR rats. Our results indicated that BBR plays a protective role in PCOS-IR, increasing insulin sensitivity, improving hyperandrogens and recovering abnormal blood lipids. Therefore, Our research provides novel insights for therapeutic treatment of BBR in patients with glucolipid metabolic disturbances.http://www.sciencedirect.com/science/article/pii/S2405844024003694Polycystic ovary syndrome (PCOS)Insulin resistance (IR)Berberine (BBR)Glucolipid metabolismPI3K-Akt signaling pathway
spellingShingle Li Li
Yao Xiao
Jiahe Zhou
Hui Mo
Xiaofang Li
Yuancheng Li
Youfeng Wang
Minglin Zhong
Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
Heliyon
Polycystic ovary syndrome (PCOS)
Insulin resistance (IR)
Berberine (BBR)
Glucolipid metabolism
PI3K-Akt signaling pathway
title Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
title_full Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
title_fullStr Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
title_full_unstemmed Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
title_short Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance
title_sort effects of berberine on glucolipid metabolism among dehydroepiandrosterone induced rats of polycystic ovary syndrome with insulin resistance
topic Polycystic ovary syndrome (PCOS)
Insulin resistance (IR)
Berberine (BBR)
Glucolipid metabolism
PI3K-Akt signaling pathway
url http://www.sciencedirect.com/science/article/pii/S2405844024003694
work_keys_str_mv AT lili effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT yaoxiao effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT jiahezhou effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT huimo effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT xiaofangli effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT yuanchengli effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT youfengwang effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance
AT minglinzhong effectsofberberineonglucolipidmetabolismamongdehydroepiandrosteroneinducedratsofpolycysticovarysyndromewithinsulinresistance